These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 32690604)

  • 21. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.
    Marisa L; de Reyniès A; Duval A; Selves J; Gaub MP; Vescovo L; Etienne-Grimaldi MC; Schiappa R; Guenot D; Ayadi M; Kirzin S; Chazal M; Fléjou JF; Benchimol D; Berger A; Lagarde A; Pencreach E; Piard F; Elias D; Parc Y; Olschwang S; Milano G; Laurent-Puig P; Boige V
    PLoS Med; 2013; 10(5):e1001453. PubMed ID: 23700391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting.
    Morris JS; Luthra R; Liu Y; Duose DY; Lee W; Reddy NG; Windham J; Chen H; Tong Z; Zhang B; Wei W; Ganiraju M; Broom BM; Alvarez HA; Mejia A; Veeranki O; Routbort MJ; Morris VK; Overman MJ; Menter D; Katkhuda R; Wistuba II; Davis JS; Kopetz S; Maru DM
    Clin Cancer Res; 2021 Jan; 27(1):120-130. PubMed ID: 33109741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Clinically Applicable Gene-Expression Classifier Reveals Intrinsic and Extrinsic Contributions to Consensus Molecular Subtypes in Primary and Metastatic Colon Cancer.
    Piskol R; Huw L; Sergin I; Kljin C; Modrusan Z; Kim D; Kljavin N; Tam R; Patel R; Burton J; Penuel E; Qu X; Koeppen H; Sumiyoshi T; de Sauvage F; Lackner MR; de Sousa E Melo F; Kabbarah O
    Clin Cancer Res; 2019 Jul; 25(14):4431-4442. PubMed ID: 31004000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
    Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
    Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of TSPAN8 in consensus molecular subtype 3 colorectal cancer.
    Suwatthanarak T; Tanjak P; Chaiboonchoe A; Acharayothin O; Thanormjit K; Chanthercrob J; Suwatthanarak T; Niyomchan A; Tanaka M; Okochi M; Pongpaibul A; Chalermwai WV; Trakarnsanga A; Methasate A; Pithukpakorn M; Chinswangwatanakul V
    Exp Mol Pathol; 2024 Jun; 137():104911. PubMed ID: 38861838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Consensus Molecular Subtype on Survival in Patients With Metastatic Colorectal Cancer: Results From CALGB/SWOG 80405 (Alliance).
    Lenz HJ; Ou FS; Venook AP; Hochster HS; Niedzwiecki D; Goldberg RM; Mayer RJ; Bertagnolli MM; Blanke CD; Zemla T; Qu X; Wirapati P; Tejpar S; Innocenti F; Kabbarah O
    J Clin Oncol; 2019 Aug; 37(22):1876-1885. PubMed ID: 31042420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.
    Chang K; Willis JA; Reumers J; Taggart MW; San Lucas FA; Thirumurthi S; Kanth P; Delker DA; Hagedorn CH; Lynch PM; Ellis LM; Hawk ET; Scheet PA; Kopetz S; Arts J; Guinney J; Dienstmann R; Vilar E
    Ann Oncol; 2018 Oct; 29(10):2061-2067. PubMed ID: 30412224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.
    Ros J; Baraibar I; Martini G; Salvà F; Saoudi N; Cuadra-Urteaga JL; Dienstmann R; Tabernero J; Élez E
    Curr Treat Options Oncol; 2021 Nov; 22(12):113. PubMed ID: 34741675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consensus molecular subgroups (CMS) of colorectal cancer (CRC) and first-line efficacy of FOLFIRI plus cetuximab or bevacizumab in the FIRE3 (AIO KRK-0306) trial.
    Stintzing S; Wirapati P; Lenz HJ; Neureiter D; Fischer von Weikersthal L; Decker T; Kiani A; Kaiser F; Al-Batran S; Heintges T; Lerchenmüller C; Kahl C; Seipelt G; Kullmann F; Moehler M; Scheithauer W; Held S; Modest DP; Jung A; Kirchner T; Aderka D; Tejpar S; Heinemann V
    Ann Oncol; 2019 Nov; 30(11):1796-1803. PubMed ID: 31868905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptomics and proteomics reveal distinct biology for lymph node metastases and tumour deposits in colorectal cancer.
    Brouwer NP; Webbink L; Haddad TS; Rutgers N; van Vliet S; Wood CS; Jansen PW; Lafarge MW; ; de Wilt JH; Hugen N; Simmer F; Jamieson NB; Tauriello DV; Kölzer VH; Vermeulen M; Nagtegaal ID
    J Pathol; 2023 Dec; 261(4):401-412. PubMed ID: 37792663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular pathological classification of colorectal cancer.
    Müller MF; Ibrahim AE; Arends MJ
    Virchows Arch; 2016 Aug; 469(2):125-34. PubMed ID: 27325016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a weakly supervised deep learning framework to predict the status of molecular pathways and key mutations in colorectal cancer from routine histology images: a retrospective study.
    Bilal M; Raza SEA; Azam A; Graham S; Ilyas M; Cree IA; Snead D; Minhas F; Rajpoot NM
    Lancet Digit Health; 2021 Dec; 3(12):e763-e772. PubMed ID: 34686474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer.
    Dunne PD; McArt DG; Bradley CA; O'Reilly PG; Barrett HL; Cummins R; O'Grady T; Arthur K; Loughrey MB; Allen WL; McDade SS; Waugh DJ; Hamilton PW; Longley DB; Kay EW; Johnston PG; Lawler M; Salto-Tellez M; Van Schaeybroeck S
    Clin Cancer Res; 2016 Aug; 22(16):4095-104. PubMed ID: 27151745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data.
    Trinh A; Lädrach C; Dawson HE; Ten Hoorn S; Kuppen PJK; Reimers MS; Koopman M; Punt CJA; Lugli A; Vermeulen L; Zlobec I
    Br J Cancer; 2018 Nov; 119(10):1244-1251. PubMed ID: 30385823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A gene expression-based single sample predictor of lung adenocarcinoma molecular subtype and prognosis.
    Liljedahl H; Karlsson A; Oskarsdottir GN; Salomonsson A; Brunnström H; Erlingsdottir G; Jönsson M; Isaksson S; Arbajian E; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
    Int J Cancer; 2021 Jan; 148(1):238-251. PubMed ID: 32745259
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.
    Trinh A; Trumpi K; De Sousa E Melo F; Wang X; de Jong JH; Fessler E; Kuppen PJ; Reimers MS; Swets M; Koopman M; Nagtegaal ID; Jansen M; Hooijer GK; Offerhaus GJ; Kranenburg O; Punt CJ; Medema JP; Markowetz F; Vermeulen L
    Clin Cancer Res; 2017 Jan; 23(2):387-398. PubMed ID: 27459899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic subtypes predict outcomes in colorectal cancer.
    Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
    Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated curation of large-scale cancer histopathology image datasets using deep learning.
    Hilgers L; Ghaffari Laleh N; West NP; Westwood A; Hewitt KJ; Quirke P; Grabsch HI; Carrero ZI; Matthaei E; Loeffler CML; Brinker TJ; Yuan T; Brenner H; Brobeil A; Hoffmeister M; Kather JN
    Histopathology; 2024 Jun; 84(7):1139-1153. PubMed ID: 38409878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive transcriptome profiling of Taiwanese colorectal cancer implicates an ethnic basis for pathogenesis.
    Wu SM; Tsai WS; Chiang SF; Lai YH; Ma CP; Wang JH; Lin J; Lu PS; Yang CY; Tan BC; Liu H
    Sci Rep; 2020 Mar; 10(1):4526. PubMed ID: 32161294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.